Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7063)
All Articles published online
|
Dec 21, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(47): 7149-7159 [PMID: 19084927 DOI: 10.3748/wjg.14.7149] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i47/7149.htm |
| Number | Citing Articles |
| 1 |
Stephen Burr, Carole Thomas, Joe Brownlie, Victoria Offord, Tracey J. Coffey, Dirk Werling. Potential evidence for biotype-specific chemokine profile following BVDV infection of bovine macrophages. Veterinary Immunology and Immunopathology 2012; 150(1-2): 123 doi: 10.1016/j.vetimm.2012.08.009
|
| 2 |
Hiroyuki Oshiumi, Kenji Funami, Hussein H. Aly, Misako Matsumoto, Tsukasa Seya. Multi-Step Regulation of Interferon Induction by Hepatitis C Virus. Archivum Immunologiae et Therapiae Experimentalis 2013; 61(2): 127 doi: 10.1007/s00005-012-0214-x
|
| 3 |
Ruben Zamora, Yoram Vodovotz, Qi Mi, Derek Barclay, Jinling Yin, Simon Horslen, David Rudnick, Kathleen M Loomes, Robert H Squires. Data-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure. Molecular Medicine 2016; 22(1): 821 doi: 10.2119/molmed.2016.00183
|
| 4 |
Dina Ragab, Melissa Laird, Darragh Duffy, Armanda Casrouge, Rasha Mamdouh, Amal Abass, Dina El. Shenawy, Abdelhadi M. Shebl, Wagdi F. Elkashef, Khaled R. Zalata, Mostafa Kamal, Gamal Esmat, Philippe Bonnard, Arnaud Fontanet, Mona Rafik, Matthew L. Albert. CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients. Cytokine 2013; 63(2): 105 doi: 10.1016/j.cyto.2013.04.016
|
| 5 |
A. Pretorius, F.E. Faber, M. van Kleef. Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4. Immunobiology 2016; 221(2): 236 doi: 10.1016/j.imbio.2015.09.002
|
| 6 |
Issam Tout, Pietro Lampertico, Thomas Berg, Tarik Asselah. Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B. Antiviral Research 2021; 185: 104992 doi: 10.1016/j.antiviral.2020.104992
|
| 7 |
Pam Kimball, Felecia McDougan, Richard Stirling. CXCR3 Expression Elevated on Peripheral CD8+Lymphocytes from HIV/HCV Coinfected Individuals. Viral Immunology 2011; 24(6): 441 doi: 10.1089/vim.2011.0035
|
| 8 |
Peng Peng Ip, Annemarie Boerma, Joke Regts, Tjarko Meijerhof, Jan Wilschut, Hans W Nijman, Toos Daemen. Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses. Molecular Therapy 2014; 22(4): 881 doi: 10.1038/mt.2013.287
|
| 9 |
Chia-Chen Lin, Shih-Huan Su, Wen-Juei Jeng, Chien-Hao Huang, Wei Teng, Wei-Ting Chen, Yi-Cheng Chen, Chun-Yen Lin, I-Shyan Sheen. CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0724-4
|
| 10 |
Marini Stephanie, Yosephine G. Susufi, Ening Krisnuhoni, Rino A. Gani, Evy Yunihastuti, Silvia Lee, Sara Tanaskovic, Patricia Price. Short Communication: Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy. AIDS Research and Human Retroviruses 2016; 32(12): 1202 doi: 10.1089/aid.2016.0042
|
| 11 |
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1): 25 doi: 10.1038/cmi.2013.37
|
| 12 |
Abdulkerim Yilmaz, Hakan Alagozlu, Ozturk Ozdemir, Sema Arici. Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients. Hepatitis Monthly 2014; 14(6) doi: 10.5812/hepatmon.11283
|
| 13 |
Veronica D. Gonzalez, Alan L. Landay, Johan K. Sandberg. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clinical Immunology 2010; 135(1): 12 doi: 10.1016/j.clim.2009.12.005
|
| 14 |
Min Zhang, Yongfang Jiang, Xinqiang Xiao, Milin Peng, Feng Peng, Guozhong Gong. Differences in IP-10, TLR4 and IRF5/3 between SVR and non-SVR HCV-1 patients treated with PEG-IFN and ribavirin. Molecular Medicine Reports 2017; 15(4): 2318 doi: 10.3892/mmr.2017.6229
|
| 15 |
Elisabetta Pandolfi, Nadia Panera, Anna Alisi, Emanuela Carloni, Luisa Russo, Ilaria Campagna, Caterina Rizzo, Carlo Concato, Giulia Linardos, Livia Piccioni, Sally Jackson, Alberto Villani, Fabio Midulla, Alberto E. Tozzi. Cytokine expression patterns in hospitalized children with Bordetella pertussis, Rhinovirus or co-infection. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89538-0
|
| 16 |
Antonios Katsounas, Joerg F. Schlaak, Richard A. Lempicki. CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus. International Reviews of Immunology 2011; 30(5-6): 366 doi: 10.3109/08830185.2011.593105
|
| 17 |
Noha Mousaad Elemam, Bariaa A. Khalil, Azzam A. Maghazachi. Encyclopedia of Infection and Immunity. 2022; : 193 doi: 10.1016/B978-0-12-818731-9.00061-6
|
| 18 |
Muttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, Li Y. Chang, Alireza Saeidi, Yean K. Yong, M. Ravishankar Ram, Kaliappan Gopal, Vijayakumar Velu, Marie Larsson, Esaki M. Shankar. Peripheral loss of CD8+CD161++TCRVα7·2+ mucosal‐associated invariant T cells in chronic hepatitis C virus‐infected patients. European Journal of Clinical Investigation 2016; 46(2): 170 doi: 10.1111/eci.12581
|
| 19 |
Natalia Fonseca Rosário, Geórgia do Nascimento Saraiva, Thalia Medeiros, Mariana Gandini, Gilmar Lacerda, Paulo Emílio Corrêa Leite, Thaís Guaraná Andrade, Elzinandes Leal Azeredo, Analúcia Rampazzo Xavier, Andrea Alice Silva. Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study. Immunology Letters 2020; 228: 15 doi: 10.1016/j.imlet.2020.09.002
|
| 20 |
Yuhua Lin, Yiwen Chai, Along Gao, Jugan Han, Yanxi Guo, Yuqing Lin, Liting Wu, Jianmin Ye. CXCL13/CXCR5 axis mediates IgM+ B cell migration through AKT and STAT3 signaling pathways in Nile tilapia (Oreochromis niloticus). Aquaculture 2024; 591: 741109 doi: 10.1016/j.aquaculture.2024.741109
|
| 21 |
Takayuki Abe, Takasuke Fukuhara, Xiauyu Wen, Akinori Ninomiya, Kohji Moriishi, Yoshihiko Maehara, Osamu Takeuchi, Taro Kawai, Shizuo Akira, Yoshiharu Matsuura. CD44 Participates in IP-10 Induction in Cells in Which Hepatitis C Virus RNA Is Replicating, through an Interaction with Toll-Like Receptor 2 and Hyaluronan. Journal of Virology 2012; 86(11): 6159 doi: 10.1128/JVI.06872-11
|
| 22 |
Olfat Shaker, Yasser Nassar, Shymaa Ayoub, Maissa Elrazki, Amr Zahra. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4. Journal of Clinical Laboratory Analysis 2016; 30(6): 1021 doi: 10.1002/jcla.21974
|
| 23 |
Nassim Dali‐Youcef, Michel Vix, Federico Costantino, Houssein El‐Saghire, Benoit Lhermitte, Cosimo Callari, Jacopo D’Agostino, Silvana Perretta, Stefan Paveliu, Monica Gualtierotti, Edith Dumeny, Marine A. Oudot, Amélie Jaulin, Doulaye Dembélé, Mirjam B. Zeisel, Catherine Tomasetto, Thomas F. Baumert, Michel Doffoël. Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance. Hepatology Communications 2019; 3(9): 1205 doi: 10.1002/hep4.1396
|
| 24 |
Bruce L Gilliam, David J Riedel, Robert R Redfield. Clinical use of CCR5 inhibitors in HIV and beyond. Journal of Translational Medicine 2011; 9(S1) doi: 10.1186/1479-5876-9-S1-S9
|
| 25 |
Shulin Qin, John F. Alcorn, Jodi K. Craigo, Charis Tjoeng, Patrick M. Tarwater, Jay K. Kolls, Todd A. Reinhart. Epigallocatechin-3-Gallate Reduces Airway Inflammation in Mice through Binding to Proinflammatory Chemokines and Inhibiting Inflammatory Cell Recruitment. The Journal of Immunology 2011; 186(6): 3693 doi: 10.4049/jimmunol.1002876
|
| 26 |
S. H. HWANG, J. A. LIM, M. J. KIM, H. C. KIM, H. W. LEE, K. Y. YOO, C. W. YOU, K. S. LEE, H. S. KIM. Profiling of differentially expressed genes in haemophilia A with inhibitor. Haemophilia 2012; 18(3) doi: 10.1111/j.1365-2516.2011.02702.x
|
| 27 |
Sheila M. Keating, Jennifer L. Dodge, Philip J. Norris, John Heitman, Stephen J. Gange, Audrey L. French, Marshall J. Glesby, Brian R. Edlin, Patricia S. Latham, Maria C. Villacres, Ruth M. Greenblatt, Marion G. Peters, Jason Blackard. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—The Women’s Interagency HIV Study. PLOS ONE 2017; 12(9): e0181004 doi: 10.1371/journal.pone.0181004
|
| 28 |
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. MacSween's Pathology of the Liver. 2024; : 1 doi: 10.1016/B978-0-7020-8228-3.00001-6
|
| 29 |
N. A. Arsentieva, A. V. Semenov, D. A. Zhebrun, E. V. Vasilyeva, Areg A. Totolian. ROLE OF CXCR3 CHEMOKINE RECEPTOR AND ITS LIGANDS IN CERTAIN DISEASES. Medical Immunology (Russia) 2019; 21(4): 617 doi: 10.15789/1563-0625-2019-4-617-632
|
| 30 |
Xiao-Wei Xu, Xiao-Xin Wu, Ke-Da Chen, Da-Zhi Chen, Hui-Lin Ou, Jun-Wei Su, Hai-Ying Yu, Hang-Ping Yao, Lan-Juan Li. Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China. Medicine 2018; 97(38): e12403 doi: 10.1097/MD.0000000000012403
|
| 31 |
Marie-Luise Berres, Christian Trautwein, Maximilian Schmeding, Dennis Eurich, Frank Tacke, Marcus Bahra, Peter Neuhaus, Ulf P. Neumann, Hermann E. Wasmuth. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology 2011; 53(2): 596 doi: 10.1002/hep.24098
|
| 32 |
Moataza H Omran, Mahmoud Khamis, Nada Nasr, Ahmed A Massoud, Samar S Youssef, Noha G. Bader El Din, Reham M Dawood, Khaled Atef, Rehab I Moustafa, Wael Nabil, Ashraf A Tabll, Mostafa K. El Awady. A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.13721
|
| 33 |
Marilyn Huckans, Bret E. Fuller, Hannah Olavarria, Anna W. Sasaki, Michael Chang, Kenneth D. Flora, Michael Kolessar, Daniel Kriz, Jeanne R. Anderson, Arthur A. Vandenbark, Jennifer M. Loftis. Multi‐analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. Brain and Behavior 2014; 4(2): 123 doi: 10.1002/brb3.200
|
| 34 |
Fernanda Cristina Winckler, Aline Marcia Marques Braz, Vanessa Nogueira da Silva, Marjorie de Assis Golim, Vanessa Gutierrez de Andrade, Paulo Eduardo de Abreu Machado, Liciana Vaz de Arruda Silveira, Giovanni Faria Silva. Influence of the inflammatory response on treatment of hepatitis C with triple therapy. Revista da Sociedade Brasileira de Medicina Tropical 2018; 51(6): 731 doi: 10.1590/0037-8682-0137-2018
|
| 35 |
Katrien Van Raemdonck, Philippe E. Van den Steen, Sandra Liekens, Jo Van Damme, Sofie Struyf. CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 2015; 26(3): 311 doi: 10.1016/j.cytogfr.2014.11.009
|
| 36 |
James M. Crawford, Alastair D. Burt. MacSween's Pathology of the Liver. 2012; : 1 doi: 10.1016/B978-0-7020-3398-8.00001-5
|
| 37 |
Mustapha Si-Tahar, Fany Blanc, Laetitia Furio, Damien Chopy, Viviane Balloy, Monique Lafon, Michel Chignard, Laurence Fiette, Francina Langa, Pierre Charneau, Julien Pothlichet. Protective Role of LGP2 in Influenza Virus Pathogenesis. The Journal of Infectious Diseases 2014; 210(2): 214 doi: 10.1093/infdis/jiu076
|
| 38 |
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz, A Mehrabi. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 2015; 113(5): 756 doi: 10.1038/bjc.2015.227
|
| 39 |
Devi Satarkar, Chinmoy Patra. Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.882017
|
| 40 |
Hu Li, Meng-Hao Huang, Jian-Dong Jiang, Zong-Gen Peng. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World Journal of Gastroenterology 2018; 24(47): 5297-5311 doi: 10.3748/wjg.v24.i47.5297
|
| 41 |
Julia Peña-Asensio, Eduardo Sanz-de-Villalobos, Joaquín Miquel, Juan Ramón Larrubia. Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history. World Journal of Hepatology 2020; 12(10): 754-765 doi: 10.4254/wjh.v12.i10.754
|
| 42 |
Cristina Stasi, Stefano Milani, Andrea Galli. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; : 129 doi: 10.1016/B978-0-12-821927-0.00005-X
|
| 43 |
Qing Lin, Dan Fang, Xinwei Hou, Yingying Le, Jiazhu Fang, Feng Wen, Wanghua Gong, Keqiang Chen, Ji Ming Wang, Shao Bo Su. HCV Peptide (C5A), an Amphipathic α-Helical Peptide of Hepatitis Virus C, Is an Activator of N-Formyl Peptide Receptor in Human Phagocytes. The Journal of Immunology 2011; 186(4): 2087 doi: 10.4049/jimmunol.1002340
|
| 44 |
A. Katsounas, M. Trippler, B. Wang, M. Polis, R. A. Lempicki, S. Kottilil, G. Gerken, J. F. Schlaak. CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon‐α therapy and toll‐like receptor 3 signalling. Journal of Viral Hepatitis 2012; 19(2): 128 doi: 10.1111/j.1365-2893.2011.01503.x
|
| 45 |
Noha Elemam, Iman Talaat, Azzam Maghazachi. CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections. Viruses 2022; 14(11): 2445 doi: 10.3390/v14112445
|
| 46 |
Hamad I. Al-Ashgar, Mohammed Q. Khan, Ahmed Helmy, Sahar Al-Thawadi, Mohammed N. Al-Ahdal, Nisreen Khalaf, Ahmed Al-Qahtani, Faisal M Sanai. Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4. European Journal of Gastroenterology & Hepatology 2013; 25(4): 404 doi: 10.1097/MEG.0b013e32835bc2cf
|
| 47 |
Suvercha Bhardwaj, Fareed Ahmad, Heiner Wedemeyer, Marcus Cornberg, Julian Schulze zur Wiesch, Jan van Lunzen, Shiv K. Sarin, Reinhold E. Schmidt, Dirk Meyer-Olson. Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0507-5
|
| 48 |
Jieru Wang, Mrinalini P. Nikrad, Tzulip Phang, Bifeng Gao, Taylor Alford, Yoko Ito, Karen Edeen, Emily A. Travanty, Beata Kosmider, Kevan Hartshorn, Robert J. Mason. Innate Immune Response to Influenza A Virus in Differentiated Human Alveolar Type II Cells. American Journal of Respiratory Cell and Molecular Biology 2011; 45(3): 582 doi: 10.1165/rcmb.2010-0108OC
|
| 49 |
Noha G. Bader El Din, Mohamed A. Anany, Reham M. Dawood, Marwa K. Ibrahim, Reem El-Shenawy, Yasmin S. El Abd, Mostafa K. El Awady. Impact ofOAS1Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients. Viral Immunology 2015; 28(9): 509 doi: 10.1089/vim.2015.0041
|
| 50 |
Yoram Vodovotz, Derek Barclay, Jinling Yin, Robert H. Squires, Ruben Zamora. Dynamics of Systemic Inflammation as a Function of Developmental Stage in Pediatric Acute Liver Failure. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.610861
|
| 51 |
G. L.‐H. Wong, Y.‐K. Tse, H. L.‐Y. Chan, T. C.‐F. Yip, K. K.‐F. Tsoi, V. W.‐S. Wong. Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B‐related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2016; 43(7): 802 doi: 10.1111/apt.13548
|
| 52 |
Nabil Azhar, Cordelia Ziraldo, Derek Barclay, David A. Rudnick, Robert H. Squires, Yoram Vodovotz, Ioannis P. Androulakis. Analysis of Serum Inflammatory Mediators Identifies Unique Dynamic Networks Associated with Death and Spontaneous Survival in Pediatric Acute Liver Failure. PLoS ONE 2013; 8(11): e78202 doi: 10.1371/journal.pone.0078202
|
| 53 |
Karin Kan, Danny Ka‐Ho Wong, Rex Wan‐Hin Hui, Wai Kay Seto, Man‐Fung Yuen, Lung‐Yi Mak. Plasma interferon‐gamma‐inducible‐protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients. Journal of Gastroenterology and Hepatology 2024; 39(1): 202 doi: 10.1111/jgh.16371
|
| 54 |
Hossein Khorramdelazad, Elham Hakimizadeh, Gholamhossein Hassanshahi, Mohammadtaghi Rezayati, Hossein Sendi, Mohammad Kazemi Arababadi. CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection. Journal of Medical Virology 2013; 85(6): 964 doi: 10.1002/jmv.23510
|
| 55 |
Susanne Johansson, Willem Talloen, Marianne Tuefferd, Jama Darling, Gregory Fanning, Michael W. Fried, Jeroen Aerssens. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV‐infected patients regardless of DPP4 activity. Liver International 2016; 36(3): 344 doi: 10.1111/liv.12932
|
| 56 |
A. de Niet, J. de Bruijne, M.J. Tempelmans Plat-Sinnige, R.B. Takkenberg, R.A.W. van Lier, H.W. Reesink, E.M.M. van Leeuwen. Upregulation of CXCR3 expression on CD8+ T cells due to the pervasive influence of chronic hepatitis B and C virus infection. Human Immunology 2013; 74(8): 899 doi: 10.1016/j.humimm.2013.04.017
|
| 57 |
Paul J Rider, Fenyong Liu. Crosstalk between HIV and hepatitis C virus during co-infection. BMC Medicine 2012; 10(1) doi: 10.1186/1741-7015-10-32
|
| 58 |
Caralee J. Schaefer, Karl Kossen, Sharlene R. Lim, Jiing-Huey Lin, Lin Pan, Williamson Bradford, Patrick F. Smith, Scott D. Seiwert. Danoprevir Monotherapy Decreases Inflammatory Markers in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy 2011; 55(7): 3125 doi: 10.1128/AAC.00131-11
|
| 59 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
| 60 |
Julia Peña-Asensio, Henar Calvo, Miguel Torralba, Joaquín Miquel, Eduardo Sanz-de-Villalobos, Juan-Ramón Larrubia. Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C. Cells 2021; 10(3): 538 doi: 10.3390/cells10030538
|
| 61 |
Beicheng Sun, Michael Karin. Inflammation and liver tumorigenesis. Frontiers of Medicine 2013; 7(2): 242 doi: 10.1007/s11684-013-0256-4
|
| 62 |
Shibin Zhang, Yan Zhao, Huiping Yan, Hao Wu, Lai Wei, Yonghong Zhang, Xinyue Chen. Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection. International Journal of Infectious Diseases 2015; 33: 15 doi: 10.1016/j.ijid.2014.08.021
|
| 63 |
Wen Zhang, Yunyun Fei, Jinming Gao, Bin Liu, Fengchun Zhang. The Role of CXCR3 in the Induction of Primary Biliary Cirrhosis. Clinical and Developmental Immunology 2011; 2011: 1 doi: 10.1155/2011/564062
|
| 64 |
Lanlan Xiao, Xiaoxin Wu, Fen Zhang, Jie Wang, Xiaowei Xu, Lanjuan Li. Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir‐boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection. Journal of Medical Virology 2020; 92(12): 3516 doi: 10.1002/jmv.26161
|
| 65 |
Nora A. Fierro, Flor P. Castro-Garcia, Arturo Panduro. Rethinking cytokine function during hepatitis A and hepatitis C infections. Advances in Bioscience and Biotechnology 2013; 4(07): 13 doi: 10.4236/abb.2013.47A1003
|
| 66 |
Man Yang, Ling Zhou, Hai-Qing Wang, Xiao-Chun Luo, Xue-Ming Dan, Yan-Wei Li. Molecular cloning and expression analysis of CCL25 and its receptor CCR9s from Epinephelus coioides post Cryptocaryon irritans infection. Fish & Shellfish Immunology 2017; 67: 402 doi: 10.1016/j.fsi.2017.06.039
|
| 67 |
Jieru Wang, Mrinalini P. Nikrad, Emily A. Travanty, Bin Zhou, Tzulip Phang, Bifeng Gao, Taylor Alford, Yoko Ito, Piruz Nahreini, Kevan Hartshorn, David Wentworth, Charles A. Dinarello, Robert J. Mason, Samithamby Jeyaseelan. Innate Immune Response of Human Alveolar Macrophages during Influenza A Infection. PLoS ONE 2012; 7(3): e29879 doi: 10.1371/journal.pone.0029879
|
| 68 |
G. L.‐H. Wong, H. L.‐Y. Chan, H.‐Y. Chan, C.‐H. Tse, A. M.‐L. Chim, A. O.‐S. Lo, V. W.‐S. Wong. Serum interferon‐inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2016; 43(1): 145 doi: 10.1111/apt.13447
|
| 69 |
Adeeb H. Rahman, Andrea D. Branch. Vitamin D for your patients with chronic hepatitis C?. Journal of Hepatology 2013; 58(1): 184 doi: 10.1016/j.jhep.2012.07.026
|
| 70 |
Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli. Cytokines and HCV-Related Disorders. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/468107
|
| 71 |
Noe Rico Montanari, Chimaobi M. Anugwom, Andre Boonstra, Jose D. Debes. The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma. Cancers 2021; 13(19): 4876 doi: 10.3390/cancers13194876
|
| 72 |
Cheng Peng, Bi-Sheng Liu, Robert J. de Knegt, Harry L.A. Janssen, André Boonstra. The response to TLR ligation of human CD16+CD14− monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus. Molecular Immunology 2011; 48(12-13): 1505 doi: 10.1016/j.molimm.2011.04.008
|
| 73 |
Silvia Martina Ferrari, Poupak Fallahi, Ilaria Ruffilli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Valeria Mazzi, Michele Colaci, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/5878960
|
| 74 |
Marie‐Luise Berres, Jennifer Lehmann, Christian Jansen, Jan Görtzen, Carsten Meyer, Daniel Thomas, Henning W. Zimmermann, Daniela Kroy, Fabienne Schumacher, Christian P. Strassburg, Tilman Sauerbruch, Christian Trautwein, Hermann E. Wasmuth, Jonel Trebicka. Chemokine (C‐X‐C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Liver International 2016; 36(3): 386 doi: 10.1111/liv.12922
|
| 75 |
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?. World Journal of Gastroenterology 2018; 24(17): 1825-1838 doi: 10.3748/wjg.v24.i17.1825
|
| 76 |
Erwin Daniel Brenndörfer, Anette Brass, Juliane Karthe, Gustaf Ahlén, Johannes Georg Bode, Matti Sällberg. Cleavage of the T Cell Protein Tyrosine Phosphatase by the Hepatitis C Virus Nonstructural 3/4A Protease Induces a Th1 to Th2 Shift Reversible by Ribavirin Therapy. The Journal of Immunology 2014; 192(4): 1671 doi: 10.4049/jimmunol.1301077
|
| 77 |
Shikha Shrivastava, Eric G. Meissner, Emily Funk, Seerat Poonia, Virender Shokeen, Arun Thakur, Bhawna Poonia, Shiv Kumar Sarin, Nirupma Trehanpati, Shyamasundaran Kottilil. Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. Hepatology International 2016; 10(6): 937 doi: 10.1007/s12072-016-9733-6
|
| 78 |
F. Cai, Y. Zhao, Q. Chen, Y. Hu, Shibing Su, Yiyu Lu. Serum Cytokine Analysis Reveals Predictors of Progression from Chronic Hepatitis B to Liver Cirrhosis. Folia Biologica 2021; 67(1): 28 doi: 10.14712/fb2021067010028
|
| 79 |
Karim Si-Tayeb, Jean-Charles Duclos-Vallée, Marie-Anne Petit. Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal. Journal of Hepatology 2012; 57(3): 689 doi: 10.1016/j.jhep.2012.04.012
|
| 80 |
Ilona Argirion, Ruth M. Pfeiffer, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien-Jen Chen, Mei-Hsuan Lee, Allan Hildesheim, Hwai-I Yang, Jill Koshiol. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00455-8
|
| 81 |
Edward Hudgens, Dannielle Tompkins, Patricia Boyd, Joan K. Lunney, David Horohov, Cynthia L. Baldwin. Expressed gene sequence of the IFNγ-response chemokine CXCL9 of cattle, horses, and swine. Veterinary Immunology and Immunopathology 2011; 141(3-4): 317 doi: 10.1016/j.vetimm.2011.02.015
|
| 82 |
Fenghuang Pan, Xinbiao Ma, Xiaoqian Tang, Jing Xing, Xiuzhen Sheng, Heng Chi, Wenbin Zhan. Genome characterization of Hirame novirhabdovirus (HIRRV) isolate CNPo2015 and transcriptome analysis of Hirame natural embryo (HINAE) cells infected with CNPo2015. Fish & Shellfish Immunology 2023; 132: 108493 doi: 10.1016/j.fsi.2022.108493
|
| 83 |
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. The Korean Journal of Internal Medicine 2020; 35(5): 1074 doi: 10.3904/kjim.2018.273
|
| 84 |
H.‐B. Kim, S.‐K. Myung, Y.‐J. Lee, B.‐J. Park. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta‐analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics 2018; 31(2): 168 doi: 10.1111/jhn.12503
|
| 85 |
Arnaud Chalin, Benjamin Lefevre, Christelle Devisme, Charlotte Pronier, Virginie Carrière, Vincent Thibault, Laurence Amiot, Michel Samson. Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury. Cytokine 2018; 111: 500 doi: 10.1016/j.cyto.2018.05.029
|
| 86 |
A. S. Moura, R. A. Carmo, A. L. Teixeira, V. H. R. Leite, M. O. C. Rocha. Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection. European Journal of Clinical Microbiology & Infectious Diseases 2010; 29(9): 1153 doi: 10.1007/s10096-010-0981-4
|
| 87 |
Lauren E. Kushner, Aaron M. Wendelboe, Laura C. Lazzeroni, Aarthi Chary, Mark A. Winters, Anu Osinusi, Shyam Kottilil, Michael A. Polis, Mark Holodniy, Ravi Jhaveri. Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients. PLoS ONE 2013; 8(4): e60387 doi: 10.1371/journal.pone.0060387
|
| 88 |
Tingting Zhang, Long Zhang, Tao Zhang, Jinhai Fan, Kaijie Wu, Zhenfeng Guan, Xinyang Wang, Lei Li, Jer-Tsong Hsieh, Dalin He, Peng Guo. Metformin Sensitizes Prostate Cancer Cells to Radiation Through EGFR/p-DNA-PKCS In Vitro and In Vivo. Radiation Research 2014; 181(6): 641 doi: 10.1667/RR13561.1
|
| 89 |
Marie-Luise Berres, Sonja Asmacher, Jennifer Lehmann, Christian Jansen, Jan Görtzen, Sabine Klein, Carsten Meyer, Holger M. Strunk, Rolf Fimmers, Frank Tacke, Christian P. Strassburg, Christian Trautwein, Tilman Sauerbruch, Hermann Elard Wasmuth, Jonel Trebicka. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. Journal of Hepatology 2015; 62(2): 332 doi: 10.1016/j.jhep.2014.09.032
|
| 90 |
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. Macsween's Pathology of the Liver. 2018; : 1 doi: 10.1016/B978-0-7020-6697-9.00001-7
|
| 91 |
Ivan Kurelac, Snjezana Zidovec Lepej, Ivana Grgic, Lana Gorenec, Neven Papic, Davorka Dusek, Bruno Barsic, Adriana Vince. Chemokine CXCL10 at Week 4 of Treatment Predicts Sustained Virological Response in Patients with Chronic Hepatitis C. Journal of Interferon & Cytokine Research 2012; 32(8): 386 doi: 10.1089/jir.2012.0006
|
| 92 |
Sergey M. Ivanov, Olga A. Tarasova, Vladimir V. Poroikov. Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1199482
|
| 93 |
Takashi Iwata, Takuma Fujii, Kenji Morii, Miyuki Saito, Juri Sugiyama, Hiroshi Nishio, Tohru Morisada, Kyoko Tanaka, Tomonori Yaguchi, Yutaka Kawakami, Daisuke Aoki. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. International Journal of Clinical Oncology 2015; 20(1): 126 doi: 10.1007/s10147-014-0680-8
|
| 94 |
Malgorzata Krzystek-Korpacka, Marek Zawadzki, Paulina Lewandowska, Krzysztof Szufnarowski, Iwona Bednarz-Misa, Krzysztof Jacyna, Wojciech Witkiewicz, Andrzej Gamian. Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery. Journal of Clinical Medicine 2019; 8(6): 879 doi: 10.3390/jcm8060879
|
| 95 |
Víctor G Martínez, Noelia M Canseco, Laura Hidalgo, Jaris Valencia, Ana Entrena, Lidia M Fernández‐Sevilla, Carmen Hernández‐López, Rosa Sacedón, Angeles Vicente, Alberto Varas. A discrete population of IFN λ‐expressing BDCA3hi dendritic cells is present in human thymus. Immunology & Cell Biology 2015; 93(7): 673 doi: 10.1038/icb.2015.22
|